The depressed brain encourages rigid thought patterns that impact well-being. This can be viewed as a “landscape” with deep wells that make it difficult for patients to “move between” different thoughts and perspectives.
Image by Richard Daws, Kings College London
Study Suggests New Mechanism for How Psychedelics Affect the Brain
Psilocybin fosters greater connections between different regions of the brain in depressed people, freeing them up from long-held patterns of rumination and excessive self-focus, according to a new study by scientists at UC San Francisco and Imperial College London.
The discovery points toward a general mechanism through which psychedelics may be acting therapeutically on the brain to alleviate depression and possibly other psychiatric conditions that are marked by fixed patterns of thinking.
Scientists analyzed fMRI brain scans from nearly 60 people who had participated in two psilocybin trials. In the first one, all the participants had treatment-resistant depression and knew they were being given psilocybin. In the second one, the participants were depressed but not as severely, and they were not told whether they had been given psilocybin or a placebo that turned out to be escitalopram, an SSRI antidepressant. In addition to the drugs, all the participants received the same type of psychotherapy.
The scans, which were done before and after treatment, showed the psilocybin treatment reduced connections within brain areas that are tightly connected in depression, including the default mode, salience, and executive networks, and increased connections to other regions of the brain that had not been well integrated.
Participants were also less emotionally avoidant and their cognitive functioning got better. The improvement in their depressive symptoms correlated with changes to their brains, and these changes lasted until the study ended three weeks after the second psilocybin dose. No such changes were seen in the brains of those who received escitalopram, suggesting that psilocybin acts differently on the brain than SSRIs.
Psilocybin and other serotonergic psychedelics like ayahuasca affect 5-HT2A receptors, which are plentiful in brain networks that become overactive in depression. One hypothesis is that the drugs briefly disrupt these connections, giving them a chance to reform in new ways in the ensuing days and weeks.
“In previous studies we had seen a similar effect in the brain when people were scanned whilst on a psychedelic, but here we’re seeing it weeks after treatment for depression, which suggests a carry-over of the acute drug action,” said Robin Carhart-Harris, PhD, who directs the Neuroscape Psychedelics Division at UCSF and is the senior author of the study, which appears April 11, 2022, in Nature Medicine.
“We don’t yet know how long the changes in brain activity seen with psilocybin therapy last, and we need to do more research to understand this,” said Carhart-Harris, who is the Ralph Metzner Distinguished Professor of Neurology, Psychiatry, and Behavioral Sciences and a member of the UCSF Weill Institute for Neurosciences. “We do know that some people relapse, and it may be that after a while their brains revert to the rigid patterns of activity we see in depression.”
The authors caution that while these findings are encouraging, patients with depression should not attempt to self-medicate with psilocybin. The trials took place under controlled, clinical conditions, using a regulated dose formulated in a laboratory, and involved extensive psychological support before, during, and after dosing.
But the study points to a mechanism that, if it holds up, may explain both how psilocybin helps to alleviate depression and potentially other debilitating psychiatric conditions.
“For the first time we find that psilocybin works differently from conventional antidepressants – making the brain more flexible and fluid, and less entrenched in the negative thinking patterns associated with depression,” said David Nutt, DM, head of the Imperial Centre for Psychedelic Research. “This supports our initial predictions and confirms psilocybin could be a real alternative approach to depression treatments.”
Original Article: Psilocybin Rewires the Brain for People with Depression
The Latest on: Psilocybin
- Psilocybin possession in Colorado not happening after initiative fails to qualify for November balloton August 9, 2022 at 4:00 pm
An initiative that would have removed criminal penalties for the possession of psilocybin and other hallucinogens in Colorado failed to gather enough signatures to appear before voters in November.
- 6Oregon Psilocybin Services Act: State Vs....on August 9, 2022 at 2:34 pm
Oregon's elected councilors in Philomath joined the debate on whether to offer their voters to “opt out” of Measure 109, the ...
- BREAKING: COMPASS Pathways Sued For Alleged Theft Of Psilocybin Trade Secretson August 9, 2022 at 11:08 am
COMPASS Pathways (NASDAQ:CMPS) for the appropriation of trade secrets. Terran, a private biotech platform company filed a complaint against COMPASS last Friday. On Monday, August 8, the case was ...
- Oregon Officials Put Psilocybin Services Bans On Local Ballots, Two Years After Voters Legalized It Statewideon August 9, 2022 at 6:59 am
I think that’s probably not going to be a good look when the voters decide that they still want this program.” By Mike McInally, Oregon Capital Chronicle On a recent Monday evening, as a heatwave ...
- County enters uncharted territory in regulating rural psilocybin serviceson August 8, 2022 at 6:30 pm
The focus of psilocybin services was still up for debate Monday, even as Deschutes County Commissioners affirmed their decision to let voters decide if they want to ban the manufacture ...
- Optimi Health To Launch Therapeutic Psilocybin Product In Partnership With Patient Advocate Thomas Hartleon August 8, 2022 at 6:00 am
Thomas Hartle Thomas Hartle touring Field Trip Health's Toronto clinic in October 2021. Optimi Health Cultivation Facility Part of Optimi's 20,000 sq ft cultivation and analytical facilities where the ...
- This Startup Wants to Use Magic Mushrooms to End Alcoholismon August 6, 2022 at 9:05 am
We want to enrich their lives, so we looked at all the different research out there and found a lot of promise with psilocybin.” Scores of pharmaceutical companies and academic institutions have ...
- Psilocybin therapy is prompting states to reconsider laws about magic mushroomson August 6, 2022 at 2:30 am
As psilocybin therapy has gained traction, states around the US have started to try to change their laws on magic mushrooms.
- Psilocybin Microdosing Shows No Benefit to Creativity, Cognition, Perception in New Scientific Studyon August 3, 2022 at 2:30 pm
If you live in Portland, chances are you have a friend who’s into microdosing: taking a small amount of magic mushrooms or LSD on a regular basis to improve their productivity, creativity, and state ...
via Bing News
The Latest on: Psilocybin
via Google News